Home | Business News | Browse by Publication | F | FDA Consumer

Expanded use of Herceptin.

Publication: FDA Consumer
Publication Date: 01-MAR-07
Format: Online
Delivery: Immediate Online Access
Full Article Title: Expanded use of Herceptin.(Updates)

Article Excerpt
In November 2006, the FDA expanded the approved use of Herceptin (trastuzumab), a biological cancer drug. This new indication is for Herceptin, in combination with other cancer drugs, as treatment of HER2 positive breast cancer after surgery (lumpectomy or mastectomy).

Herceptin is a targeted therapy against the HER2 protein on cancer cells. When an excessive amount of HER2 protein is present, it causes cancer cells...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from FDA Consumer
New treatment for head and neck cancer.(Updates), March 01, 2007

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.